Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

Volume 7, Number 7, October 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies
pp. 961-964(4)
Authors: Yan, Li; Davis, Hugh M

Bulletin Board

Biomarkers to improve cancer detection
pp. 965-967(3)

Conference Scene

Human Variome Project: an international collaboration to catalogue human genetic variation
pp. 969-972(4)
Authors: Ring, Huijun Z; Kwok, Pui-Yan; Cotton, Richard GH

Research Report

Development and clinical evaluation of oligonucleotide microarray for HLA-AB genotyping
pp. 973-985(13)
Authors: Zhang, Fan; Hu, Shouwang; Huang, Jian; Wang, Hui; Wen, Zheng; Yongyao, Geng; Wang, Shengqi

Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients
pp. 987-993(7)
Authors: Xing, Qinghe; Gao, Rui; Li, Huafang; Feng, Guoyin; Xu, Mingqing; Duan, Shiwei; Meng, Junwei; Zhang, Aiping; Qin, Shengying; He, Lin

Pyrosequencing™-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance
pp. 995-1002(8)
Authors: Rohrbacher, Maren; Kirchhof, Anja; Geisslinger, Gerd; Lötsch, Jörn

Toxicogenomics strategies for predicting drug toxicity
pp. 1003-1016(14)
Authors: Martin, Rory; Rose, David; Yu, Kai; Barros, Scott

An artificial neural network approach to the drug efficacy of interferon treatments
pp. 1017-1024(8)
Authors: Lin, Eugene; Hwang, Yuchi; Wang, Shu-Ching; Gu, Z John; Chen, Ellson Y

Review

Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix® database
pp. 1025-1044(20)
Authors: Ganter, Brigitte; Snyder, Ronald D; Halbert, Donald N; Lee, May D

Perspective

Perspectives on development of a combination pharmacogenomic diagnostic and drug product
pp. 1045-1049(5)
Authors: McCamish, Mark; Izumi, Raquel

Editorial

Metabolomics Special Focus: an introduction
pp. 1053-1054(2)
Author: Schnackenberg, Laura K

Review

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
pp. 1055-1075(21)
Authors: Schlotterbeck, Götz; Ross, Alfred; Dieterle, Frank; Senn, Hans

Monitoring the health to disease continuum with global metabolic profiling and systems biology
pp. 1077-1086(10)
Authors: Schnackenberg, Laura K; Beger, Richard D

Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?
pp. 1087-1094(8)
Authors: van der Greef, Jan; Hankemeier, Thomas; McBurney, Robert N

Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders
pp. 1095-1107(13)
Authors: Griffin, Julian L; Nicholls, Andrew W

Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
pp. 1109-1123(15)
Authors: Glunde, Kristine; Serkova, Natalie J

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A